Miller Marlene R, Robinson Karen A, Lubomski Lisa H, Rinke Michael L, Pronovost Peter J
Department of Pediatrics, Johns Hopkins University, Baltimore, Maryland, USA.
Qual Saf Health Care. 2007 Apr;16(2):116-26. doi: 10.1136/qshc.2006.019950.
Although children are at the greatest risk for medication errors, little is known about the overall epidemiology of these errors, where the gaps are in our knowledge, and to what extent national medication error reduction strategies focus on children.
To synthesise peer reviewed knowledge on children's medication errors and on recommendations to improve paediatric medication safety by a systematic literature review.
PubMed, Embase and Cinahl from 1 January 2000 to 30 April 2005, and 11 national entities that have disseminated recommendations to improve medication safety.
Inclusion criteria were peer reviewed original data in English language. Studies that did not separately report paediatric data were excluded.
Two reviewers screened articles for eligibility and for data extraction, and screened all national medication error reduction strategies for relevance to children.
From 358 articles identified, 31 were included for data extraction. The definition of medication error was non-uniform across the studies. Dispensing and administering errors were the most poorly and non-uniformly evaluated. Overall, the distributional epidemiological estimates of the relative percentages of paediatric error types were: prescribing 3-37%, dispensing 5-58%, administering 72-75%, and documentation 17-21%. 26 unique recommendations for strategies to reduce medication errors were identified; none were based on paediatric evidence.
Medication errors occur across the entire spectrum of prescribing, dispensing, and administering, are common, and have a myriad of non-evidence based potential reduction strategies. Further research in this area needs a firmer standardisation for items such as dose ranges and definitions of medication errors, broader scope beyond inpatient prescribing errors, and prioritisation of implementation of medication error reduction strategies.
尽管儿童发生用药错误的风险最高,但对于这些错误的总体流行病学情况、我们知识上的空白以及国家减少用药错误策略在多大程度上关注儿童,我们了解得很少。
通过系统的文献综述,综合关于儿童用药错误以及改善儿科用药安全建议的同行评审知识。
2000年1月1日至2005年4月30日的PubMed、Embase和Cinahl,以及11个已发布改善用药安全建议的国家实体。
纳入标准为英文的同行评审原始数据。未单独报告儿科数据的研究被排除。
两名评审员筛选文章以确定其是否符合纳入标准并进行数据提取,同时筛选所有国家减少用药错误策略与儿童的相关性。
从识别出的358篇文章中,纳入31篇进行数据提取。各项研究中用药错误的定义并不统一。调配和给药错误的评估最为欠缺且不一致。总体而言,儿科错误类型相对百分比的分布流行病学估计为:处方开具3% - 37%,调配5% - 58%,给药72% - 75%,记录17% - 21%。确定了26条关于减少用药错误策略的独特建议;均无基于儿科证据。
用药错误发生在处方开具、调配和给药的全过程,很常见,并且有大量缺乏证据支持的潜在减少策略。该领域的进一步研究需要在诸如剂量范围和用药错误定义等项目上有更严格的标准化,超越住院处方错误有更广泛的范围,以及对减少用药错误策略的实施进行优先排序。